Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UBS Downgrades Huntsman to Neutral

UBS Downgrades Huntsman to Neutral

UBS analyst Joshua Spector downgrades Huntsman (NYSE:HUN) from Buy to Neutral.

byBenzinga Newsdesk

July 25, 2022

1 minute read

UBS analyst Joshua Spector downgrades Huntsman (NYSE:HUN) from Buy to Neutral.

Exela Technologies Signs New Logo, Initial Total Contract Value Is $12M Over The 3-Year Contract

By Benzinga Newsdesk

September 20, 8:41 AM

FRANKFURT, Germany, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exela") (NASDAQ: XELA, XELAP), today announced a contract with a leader in communications across Europe. Exela will

XELA

Tonix Pharmaceuticals Announces Oral Presentations Involving TNX-1500 At International Congress Of The Transplantation Society

By Bill Haddad

September 6, 7:12 AM

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced three oral presentations by academic collaborators at the 29th International Congress

TNXP